Drug intelligence / Profile preview

bletilla striata oligosaccharides

Development stage
Preclinical
Lead developer
Guangdong Pharmaceutical University
Modality
Microbiome-Derived Products → Microbiome Therapeutics, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Oral
01

Overview

**Bletilla striata oligosaccharides** are low molecular weight neutral polysaccharides predominantly composed of glucose and mannose, extracted and purified from the tubers of the traditional Chinese medicinal plant *Bletilla striata*. Their primary mechanisms of action involve anti-inflammatory effects, protection of the intestinal mucosal barrier, and modulation of gut microbiota. They have demonstrated efficacy in preclinical models for alleviating chemotherapy-induced intestinal mucositis and improving ulcerative colitis, mainly by attenuating inflammatory cytokines (e.g., IL-6, TNF-α, IL-1β), enhancing tight junction protein and mucin expression, and regulating gut microbial composition. The TLR4-NF-κB/Myd88 signaling pathway has been implicated as a key anti-inflammatory mechanism. BO differ from larger Bletilla striata polysaccharides in having lower molecular weight, improved solubility, and higher stability, making them more suitable for dietary supplement use for gastrointestinal protection[1][4][5].

Other names
BO
02

Targets

MYD88 (Myeloid differentiation primary response protein MyD88)NF-κBTLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on bletilla striata oligosaccharides.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bletilla striata oligosaccharides.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call